Proteolytic cleavages give receptor tyrosine kinases the gift of ubiquity
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Molecular Biology
Link
http://www.nature.com/articles/onc200988.pdf
Reference102 articles.
1. Allouche M . (2007). ALK is a novel dependence receptor: potential implications in development and cancer. Cell Cycle 6: 1533–1538.
2. Amit I, Wides R, Yarden Y . (2007). Evolvable signaling networks of receptor tyrosine kinases: relevance of robustness to malignancy and to cancer therapy. Mol Syst Biol 3: 151.
3. Arasada RR, Carpenter G . (2005). Secretase-dependent tyrosine phosphorylation of Mdm2 by the ErbB-4 intracellular domain fragment. J Biol Chem 280: 30783–30787.
4. Athauda G, Giubellino A, Coleman JA, Horak C, Steeg PS, Lee MJ et al. (2006). c-Met ectodomain shedding rate correlates with malignant potential. Clin Cancer Res 12: 4154–4162.
5. Bache KG, Slagsvold T, Stenmark H . (2004). Defective downregulation of receptor tyrosine kinases in cancer. EMBO J 23: 2707–2712.
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Soluble Platelet-Derived Growth Factor Receptor-β Originates via Pre-mRNA Splicing in the Healthy Brain and Is Upregulated during Hypoxia and Aging;Biomolecules;2023-04-21
2. A Soluble Platelet-Derived Growth Factor Receptor-β Originates via Pre-mRNA Splicing in the Healthy Brain and is Differentially Regulated during Hypoxia and Aging;2023-02-04
3. Does a rare mutation in PTPRA contribute to the development of Parkinson’s disease in an Australian multi-incident family?;PLOS ONE;2022-07-28
4. G-749 Promotes Receptor Tyrosine Kinase TYRO3 Degradation and Induces Apoptosis in Both Colon Cancer Cell Lines and Xenograft Mouse Models;Frontiers in Pharmacology;2021-10-14
5. Novel Pyridine Bioisostere of Cabozantinib as a Potent c-Met Kinase Inhibitor: Synthesis and Anti-Tumor Activity against Hepatocellular Carcinoma;International Journal of Molecular Sciences;2021-09-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3